Eledon Pharmaceuticals (ELDN) Prepaid Assets (2013 - 2026)
Eledon Pharmaceuticals (ELDN) posted Prepaid Assets of $2.5 million for Q1 2026, up 1024.43% on a QoQ basis from $221000.0 in Q4 2025, and up 4418.18% year-over-year from $55000.0 in Q1 2025.
Eledon Pharmaceuticals (ELDN) Prepaid Assets (2013 - 2026) Analysis & Trends
Eledon Pharmaceuticals' Prepaid Assets history runs 14 years deep, the most recent figure standing at $2.5 million for Q1 2026.
- Quarterly Prepaid Assets rose 4418.18% year-over-year to $2.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.5 million (up 4418.18% YoY) and the FY2025 annual result came in at $221000.0, down 93.78% from the prior year.
- Prepaid Assets was $2.5 million for Q1 2026 at Eledon Pharmaceuticals, up from $221000.0 in the prior quarter.
- Across five years, Prepaid Assets topped out at $5.1 million in Q1 2024 and bottomed at $10000.0 in Q2 2025.
- A 5-year average of $1.4 million and a median of $287000.0 in 2024 frame the typical range for Prepaid Assets.
- Annual changes were most pronounced in 2024 — Prepaid Assets soared 10782.98% — and 2025, when it sank 98.92%.
- Eledon Pharmaceuticals' Prepaid Assets stood at $3.1 million in 2022, then sank by 94.05% to $185000.0 in 2023, then surged by 1820.0% to $3.6 million in 2024, then tumbled by 93.78% to $221000.0 in 2025, then jumped by 1024.43% to $2.5 million in 2026.
- Business Quant data shows ELDN's Prepaid Assets at $2.5 million in Q1 2026, $221000.0 in Q4 2025, and $248000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,861.65 Bn | 66,861.36 Bn | - |
| 2 | Nanobiotix | 1,935.05 Bn | 1,934.98 Bn | - |
| 3 | Akari Therapeutics | 1,023.69 Bn | 1,023.69 Bn | - |
| 4 | BeOne Medicines | 468.59 Bn | 463.80 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 123.01 Bn | 115.76 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.29 Bn | 61.53 Bn | 3.31 Bn |
| 7 | Belite Bio | 63.33 Bn | 63.33 Bn | - |
| 8 | Argenx Se | 55.70 Bn | 50.52 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.79 Bn | 34.78 Bn | 959.66 Mn |
| 10 | Eledon Pharmaceuticals | 405.29 Mn | 405.29 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.49 Mn |
| Dec 31, 2025 | 221,000.00 |
| Sep 30, 2025 | 248,000.00 |
| Jun 30, 2025 | 10,000.00 |
| Mar 31, 2025 | 55,000.00 |
| Dec 31, 2024 | 3.55 Mn |
| Sep 30, 2024 | 3.32 Mn |
| Jun 30, 2024 | 287,000.00 |
| Mar 31, 2024 | 5.12 Mn |
| Dec 31, 2023 | 185,000.00 |
| Sep 30, 2023 | 90,000.00 |
| Jun 30, 2023 | 2.24 Mn |
| Mar 31, 2023 | 47,000.00 |
| Dec 31, 2022 | 3.11 Mn |
| Sep 30, 2022 | 1.68 Mn |
| Jun 30, 2022 | 698,000.00 |
| Mar 31, 2022 | 17,000.00 |
| Dec 31, 2021 | 96,000.00 |
| Sep 30, 2021 | 1.52 Mn |
| Jun 30, 2021 | 11,000.00 |